Artiva Biotherapeutics, Inc.
ARTV • XNAS
Artiva Biotherapeutics, Inc. is a biological products, (no disgnostic substances) company trading on XNAS, led by CEO Fred Aslan, with a market cap of $168.1M.
Market Cap$168.1M
CEOFred Aslan
CountryUnited States of America
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
Artiva Biotherapeutics, Inc. FAQ
Common questions about Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 7, 2026.